Plasma Hepcidin Levels in Healthy Children from Chandigarh, Northern India

Prateek Bhatia1, Rajendra Marathe, Avani Hegde

  • 1Department of Paediatrics, Advanced Paediatrics Centre, PGIMER, Chandigarh, India. prateekbhatia@rediffmail.com.

Indian Pediatrics
|July 25, 2017
PubMed

Insights

This study establishes normal hepcidin ranges in healthy Indian children. These findings provide crucial reference values for pediatric iron homeostasis assessment.

Area of Science:

  • Pediatrics
  • Biochemistry
  • Hematology

Background:

  • Hepcidin is a critical peptide hormone regulating iron metabolism.
  • Understanding normal hepcidin levels is essential for diagnosing iron-related disorders.

Purpose of the Study:

  • To determine the normal reference ranges for plasma hepcidin concentrations in healthy children from Chandigarh, Northern India.
  • To establish age-specific and sex-specific hepcidin ranges for pediatric populations.

Main Methods:

  • Plasma samples were collected from 50 healthy children in Chandigarh, Northern India.
  • Hepcidin levels were measured using a validated assay.
  • Data were analyzed to establish mean, standard deviation, and ranges for different age groups and sexes.

Main Results:

  • Normal hepcidin ranges were established: 19.96-36.6 ng/mL for children aged 0-2 years and 9.54-36.15 ng/mL for children aged 2-6 years.
  • The mean hepcidin level was 32.5 (4.84) ng/mL for 0-2 years and 31.13 (6.62) ng/mL for 2-6 years.
  • Mean hepcidin levels were comparable between boys (31.01 ± 6.71 ng/mL) and girls (32.7 ± 4.14 ng/mL).

Conclusions:

  • This study provides the first reference ranges for plasma hepcidin in healthy North Indian children.
  • These established ranges are vital for the accurate clinical assessment of iron status and related conditions in pediatric patients.
  • The findings support the use of hepcidin as a biomarker for iron homeostasis in Indian children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...